Article
Retinal blinding disorders and gene therapy--molecular and clinical aspects.
Current gene therapy - 1 Oct 2010
Lorenz Birgit, Preising Markus, Stieger Knut
Abstract excerpt
Retinal blinding disorders together have a prevalence of 1 in 2000 humans world wide and represent a significant impact on the quality of life as well as the possibility to attain personal achievements. Mutations in genes that are expressed either in RPE cells, photoreceptors or bipolar cells can cause varying forms of degenerative or stationary retinal disorders, as the presence of the encoded proteins is...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
